(Q40939793)

25 September 2017

1 reference

title

In vitro activity of fluoroquinolones against gram-positive bacteria (English)

1 reference

25 September 2017

gram-positive bacteria

0 references

author name string

Eliopoulos GM

series ordinal

1

1 reference

25 September 2017

1 January 1995

1 reference

25 September 2017

1 reference

25 September 2017

49 Suppl 2

1 reference

25 September 2017

48-57

1 reference

The in-vitro activity of a new highly active quinolone, DU-6859a

25 September 2017

1 reference

12 December 2020

Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates

1 reference

12 December 2020

The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone

1 reference

12 December 2020

In vitro and in vivo evaluations of A-80556, a new fluoroquinolone

1 reference

12 December 2020

In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency

1 reference

12 December 2020

In vitro activity of OPC-17116

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone

1 reference

12 December 2020

In vitro activity of Bay y 3118, a new quinolone

1 reference

12 December 2020

Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone

1 reference

12 December 2020

Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin

1 reference

12 December 2020

In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study.

1 reference

12 December 2020

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1 reference

12 December 2020

In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative

1 reference

12 December 2020

In vitro activity of T-3761, a new fluoroquinolone

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent

1 reference

12 December 2020

The in-vitro susceptibilities of 326 Streptococcus pneumoniae isolates to nine antimicrobial agents including penicillin and newer quinolones

1 reference

12 December 2020

In vitro antibacterial activity of Q-35, a new fluoroquinolone

1 reference

12 December 2020

Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent

1 reference

12 December 2020

In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents

1 reference

12 December 2020

In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone

1 reference

12 December 2020

In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent

1 reference

12 December 2020

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

1 reference

12 December 2020

In-vitro activity of PD 131628, a new quinolone antimicrobial agent

1 reference

12 December 2020

Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.

1 reference

12 December 2020

Bactericidal activity of the fluoroquinolone WIN 57273 against high-level gentamicin-resistant Enterococcus faecalis

1 reference

12 December 2020

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone

1 reference

12 December 2020

Comparative in vitro activities of new quinolones against coryneform bacteria

1 reference

12 December 2020

Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci

1 reference

12 December 2020

In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections

1 reference

12 December 2020

Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones

1 reference

12 December 2020

Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

1 reference

12 December 2020

Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria

1 reference

12 December 2020

Bactericidal activities of DU-6859a and clinafloxacin (CI-960) against staphylococci

1 reference

12 December 2020

Antimicrobial activity of DV-7751a, a new fluoroquinolone

1 reference

12 December 2020

Identifiers

PubMed ID

8549407

1 reference

PubMed ID

8549407